| Guideline: delayed umbilical cord clamping for improved maternal and infant health and nutrition outcomes World Health Organization Guideline: delayed umbilical cord clamping for improved maternal and infant …, 2014 | 304* | 2014 |
| Best practices for evaluating single nucleotide variant calling methods for microbial genomics ND Olson, SP Lund, RE Colman, JT Foster, JW Sahl, JM Schupp, P Keim, ... Frontiers in genetics 6, 235, 2015 | 234 | 2015 |
| The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 192 | 2022 |
| Effect of Repeat Copy Number on Variable-Number Tandem Repeat Mutations in Escherichia coli O157:H7 AJ Vogler, C Keys, Y Nemoto, RE Colman, Z Jay, P Keim Journal of bacteriology 188 (12), 4253-4263, 2006 | 142 | 2006 |
| Rapid drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates directly from clinical samples by use of amplicon sequencing: a proof-of-concept study RE Colman, J Anderson, D Lemmer, E Lehmkuhl, SB Georghiou, ... Journal of clinical microbiology 54 (8), 2058-2067, 2016 | 118 | 2016 |
| Detection of low-level mixed-population drug resistance in Mycobacterium tuberculosis using high fidelity amplicon sequencing RE Colman, JM Schupp, ND Hicks, DE Smith, JL Buchhagen, F Valafar, ... PloS one 10 (5), e0126626, 2015 | 111 | 2015 |
| Application of targeted next-generation sequencing assay on a portable sequencing platform for culture-free detection of drug-resistant tuberculosis from clinical samples AM Cabibbe, A Spitaleri, S Battaglia, RE Colman, A Suresh, S Uplekar, ... Journal of clinical microbiology 58 (10), 10.1128/jcm. 00632-20, 2020 | 107 | 2020 |
| Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation RE Colman, A Mace, M Seifert, J Hetzel, H Mshaiel, A Suresh, D Lemmer, ... PLoS Medicine 16 (4), e1002794, 2019 | 85 | 2019 |
| Phylogenetic and genomic diversity in isolates from the globally distributed Acinetobacter baumannii ST25 lineage JW Sahl, M Del Franco, S Pournaras, RE Colman, N Karah, L Dijkshoorn, ... Scientific reports 5 (1), 15188, 2015 | 80 | 2015 |
| Whole Genome Sequence Typing to Investigate the Apophysomyces Outbreak following a Tornado in Joplin, Missouri, 2011 KA Etienne, J Gillece, R Hilsabeck, JM Schupp, R Colman, SR Lockhart, ... PLoS One 7 (11), e49989, 2012 | 76 | 2012 |
| Within-Host Evolution of Burkholderia pseudomallei in Four Cases of Acute Melioidosis EP Price, HM Hornstra, D Limmathurotsakul, TL Max, DS Sarovich, ... PLoS pathogens 6 (1), e1000725, 2010 | 75 | 2010 |
| Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens M Kaestli, LJ Richardson, RE Colman, A Tuanyok, EP Price, JR Bowers, ... Journal of Clinical Microbiology 50 (6), 2059-2062, 2012 | 71 | 2012 |
| Mixed Mycobacterium tuberculosis–Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis … SS Shin, C Modongo, Y Baik, C Allender, D Lemmer, RE Colman, ... The Journal of infectious diseases 218 (12), 1974-1982, 2018 | 62 | 2018 |
| The effects of signal erosion and core genome reduction on the identification of diagnostic markers JW Sahl, AJ Vazquez, CM Hall, JD Busch, A Tuanyok, M Mayo, ... MBio 7 (5), 10.1128/mbio. 00846-16, 2016 | 60 | 2016 |
| Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance JZ Metcalfe, E Streicher, G Theron, RE Colman, R Penaloza, C Allender, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 00888-17, 2017 | 55 | 2017 |
| Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance JZ Metcalfe, E Streicher, G Theron, RE Colman, C Allender, D Lemmer, ... American journal of respiratory and critical care medicine 196 (9), 1191-1201, 2017 | 51 | 2017 |
| Phylogenetically typing bacterial strains from partial SNP genotypes observed from direct sequencing of clinical specimen metagenomic data JW Sahl, JM Schupp, DA Rasko, RE Colman, JT Foster, P Keim Genome medicine 7, 1-13, 2015 | 46 | 2015 |
| Diverse Burkholderia Species Isolated from Soils in the Southern United States with No Evidence of B. pseudomallei CM Hall, JD Busch, K Shippy, CJ Allender, M Kaestli, M Mayo, JW Sahl, ... PLoS One 10 (11), e0143254, 2015 | 39 | 2015 |
| Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: comparative genomics associated with differential virulence JW Sahl, CJ Allender, RE Colman, KJ Califf, JM Schupp, BJ Currie, ... PLoS One 10 (3), e0121052, 2015 | 33 | 2015 |
| Fine-scale identification of the most likely source of a human plague infection RE Colman, AJ Vogler, JL Lowell, KL Gage, C Morway, PJ Reynolds, ... Emerging infectious diseases 15 (10), 1623, 2009 | 25 | 2009 |
Paul KeimRegents Professor, Northern Arizona University, TGen, Executive Director of Pathogen and McrobiomeВерификована је имејл адреса на nau.edu
